10x Genomics Company Description

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section.

It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014.

10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

10x Genomics, Inc.

Country	United States
Founded	2012
Industry	In Vitro and In Vivo Diagnostic Substances
Employees	1,306
CEO	Serge Saxonov

Contact Details

Address: 6230 Stoneridge Mall Road Pleasanton, Delaware 94588-3260 United States
Phone	(925) 401-7300
Website	10xgenomics.com

Stock Details

Ticker Symbol	0A88
Exchange	London Stock Exchange
Stock Type	Common Stock
Share Class	Class A Shares
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2835

Key Executives

Name	Position
Serge Saxonov	Chief Executive Officer
Adam Taich	Chief Financial Officer
Jim Goodrich	Chief Operating Officer
Cassie Corneau	Head of Investor Relations